0001140361-26-020025
SEC filingSolid revenue growth from higher patient visits and rates was offset by sharp profitability declines driven by clinic cost inflation and ERP implementation expenses, resulting in operating income down 36.5% to $12.5M.
Cash flow turned positive, with net cash provided by operating activities reaching $3.8 million versus a $4.7 million outflow last year, supporting ongoing investments in clinic expansions and non-controlling interests. Management notes these activities align with strategic growth, including equity acquisitions in partnerships and hospital affiliation contracts. Liquidity position remains robust, with cash equivalents and Senior Credit Facilities availability deemed sufficient for working capital through at least March 31, 2027. Investors should note forward-looking statements carry risks that could impact results, as highlighted in the MD&A.